GE Healthcare opens "China's lung cancer screening and early diagnosis and treatment"

The “China Lung Screening and Early Diagnosis and Early Action” is the first national action taken by China for lung cancer, a major disease threatening the health of Chinese people. It covers screening guidelines, lung cancer prevention knowledge, and large-scale screening. A series of activities such as investigation will open the standardization road for early diagnosis of lung cancer in China and help the implementation and development of the healthy China strategy. Leaders of the National Health and Family Planning Commission, the National Cancer Center, provincial cancer centers, cancer hospital leaders, and well-known experts in the field of lung cancer prevention and treatment, and relevant leaders of GE Healthcare Greater China attended the meeting and delivered speeches.

GE Healthcare opens "China's lung cancer screening and early diagnosis and treatment"

According to the National Cancer Statistics released by the National Cancer Center in 2015, lung cancer morbidity and mortality have the fastest growth rate in recent years. In 2015, the number of new lung cancer cases exceeded 730,000, and the death toll was about 610,000. Mortality ranks first. Natural environment, aging society and urbanization development are also increasingly challenging the challenges of lung cancer, leading to lung cancer has become one of the most serious public health problems in China. Faced with the problem of lung cancer prevention and control, it is urgent to cooperate with the health management departments, medical institutions, industry experts and related enterprises, and promote the prevention and control work through a series of standards and guidelines, and related knowledge popularization.

In this action, the National Cancer Center, in conjunction with provincial cancer centers, cancer hospitals and GE Healthcare, is based on a comprehensive and in-depth cooperation between the two sides in the prevention and treatment of lung cancer, and jointly promotes early diagnosis and early treatment of lung cancer and low-dose spiral CT lung cancer screening. Check the implementation in China. The National Cancer Center will organize authoritative industry experts from across the country, combined with long-term accumulated clinical experience and large-scale research at home and abroad, to compile the "Guidelines for Screening and Early Diagnosis and Treatment of Lung Cancer in China" based on expert consensus. The guide aims to unify doctors' awareness of early lung cancer screening, including low-dose spiral CT for lung cancer screening, comprehensively improve early diagnosis of lung cancer, and standardize clinical practice. At the same time, the National Cancer Center will also organize a team of experts to hold lectures on lung cancer screening technology and lung cancer prevention and control knowledge in more than ten cities across the country, and will launch the first large-scale low-dose spiral CT lung cancer screening and clinic activities nationwide. .

GE Healthcare adheres to the “Caring for First” market strategy and continues to focus on the challenges of lung cancer screening and diagnosis in China. It is the first in the industry to provide comprehensive support for screening operations through the FDA-approved low-dose spiral CT lung cancer screening solution. In the national publicity activities, GE Healthcare will also help spread cancer knowledge and raise public awareness of early health. In addition, GE Healthcare will integrate high-quality resources around the world to provide various equipment platforms and technical support for scientific research and clinical diagnosis and treatment of lung cancer screening for national cancer prevention centers and other Chinese cancer prevention and treatment institutions; integration of life science business resources From lung cancer screening, diagnosis and treatment, combined with quantitative imaging and clinical, pathological, genetic and other big data information, further exploration in the field of precision diagnosis, image-based treatment and efficacy evaluation.

Medical Examination Gloves

Medical Exam Gloves, Latex Sterile Gloves, Gloves for Medical Use, Medical Examination Glove Manufacturer

Ningbo Siny Medical Technology Co., Ltd , https://www.sinymedical.com

Posted on